The increase came as prescription rates held relatively steady for other key classes of behavioral health medications used to treat conditions such as depression and anxiety.
Lisa Cosgrove, a clinical psychologist at the University of Massachusetts, Boston, who was not involved in the study, said the results seem counterintuitive, since the pandemic was a time when most people were not in school or offices, environments where attention-related issues often come to light.
[
add
]
[
|
|
...
]